Related Experiment Video
Updated: Feb 14, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Merits and complexities of modeling multiple sclerosis in non-human primates: implications for drug discovery
Bert A 't Hart1,2, Jon D Laman2, Yolanda S Kap1
1a Department of Immunobiology , Biomedical Primate Research Centre , Rijswijk , The Netherlands.
Introduction:
The translation of scientific discoveries made in animal models into effective treatments for patients often fails, indicating that currently used disease models in preclinical research are insufficiently predictive for clinical success. An often-used model in the preclinical research of autoimmune neurological diseases, multiple sclerosis in particular, is experimental autoimmune encephalomyelitis (EAE). Most EAE models are based on genetically susceptible inbred/SPF mouse strains used at adolescent age (10-12 weeks), which lack exposure to genetic and microbial factors which shape the human immune system. Areas covered: Herein, the authors ask whether an EAE model in adult non-human primates from an outbred conventionally-housed colony could help bridge the translational gap between rodent EAE models and MS patients. Particularly, the authors discuss a novel and translationally relevant EAE model in common marmosets (Callithrix jacchus) that shares remarkable pathological similarity with MS. Expert opinion: The MS-like pathology in this model is caused by the interaction of effector memory T cells with B cells infected with the γ1-herpesvirus (CalHV3), both present in the pathogen-educated marmoset immune repertoire. The authors postulate that depletion of only the small subset (<0.05%) of CalHV3-infected B cells may be sufficient to limit chronic inflammatory demyelination.
Insights
Developing a more predictive multiple sclerosis (MS) model using adult non-human primates is crucial. This study explores an experimental autoimmune encephalomyelitis (EAE) model in marmosets, showing MS-like pathology and potential therapeutic targets.
Area of Science:
- Neuroimmunology
- Translational Medicine
- Primate Models
Background:
- Current preclinical models for multiple sclerosis (MS) inadequately predict clinical success.
- Experimental autoimmune encephalomyelitis (EAE) in adolescent mice lacks human immune system complexity.
- A translational gap exists between animal models and human patient outcomes.
Purpose of the Study:
- To evaluate an experimental autoimmune encephalomyelitis (EAE) model in adult non-human primates.
- To determine if a conventionally-housed marmoset model can bridge the translational gap for MS research.
- To investigate a novel EAE model with pathological similarities to MS.
Main Methods:
- Utilizing adult common marmosets (Callithrix jacchus) in a conventionally-housed colony.
- Inducing experimental autoimmune encephalomyelitis (EAE) in marmosets.
- Analyzing the pathological similarities between the marmoset EAE model and human MS.
Main Results:
- The marmoset EAE model exhibits remarkable pathological similarity to human MS.
- MS-like pathology arises from interactions between effector memory T cells and γ1-herpesvirus (CalHV3)-infected B cells.
- A small subset of CalHV3-infected B cells (<0.05%) is implicated in chronic inflammatory demyelination.
Conclusions:
- An EAE model in adult, pathogen-educated marmosets offers enhanced translational relevance for MS.
- Targeting CalHV3-infected B cells may be a viable strategy to limit MS-like pathology.
- This primate model could improve the prediction of therapeutic efficacy for MS treatments.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Bioequivalence of Drugs: Drugs with Multiple Indications
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Multiple Allele Traits
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

